Gene Modification Strategies to Induce Tumor Immunity
- 30 April 2005
- Vol. 22 (4) , 403-414
- https://doi.org/10.1016/j.immuni.2005.03.007
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Cytokines in cancer immunity and immunotherapyImmunological Reviews, 2004
- Adenovirus Vector-Mediatedin VivoGene Transfer of OX40 Ligand to Tumor Cells Enhances Antitumor Immunity of Tumor-Bearing HostsCancer Research, 2004
- Intratumoral Administration of Dendritic Cells Overexpressing CCL21 Generates Systemic Antitumor Responses and Confers Tumor ImmunityClinical Cancer Research, 2004
- Reprogramming of Virus-specific T Cells into Leukemia-reactive T Cells Using T Cell Receptor Gene TransferThe Journal of Experimental Medicine, 2004
- AAV-encoded expression of TRAIL in experimental human colorectal cancer leads to tumor regressionGene Therapy, 2004
- Comparative analysis of dendritic cells transduced with different anti‐apoptotic molecules: sensitivity to tumor‐induced apoptosisThe Journal of Gene Medicine, 2004
- A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined ImmunodeficiencyNew England Journal of Medicine, 2003
- Intratumoral Delivery of Adenovirus-Mediated Interleukin-12 Gene in Mice with Metastatic Cancer in the LiverHuman Gene Therapy, 2002
- Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathwayEuropean Journal of Immunology, 1998
- Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma CellsScience, 1993